Vascular Endothelial Growth Factor B (VEGF-B) Binds to VEGF Receptor-1 and Regulates Plasminogen Activator Activity in Endothelial Cells

The vascular endothelial growth factor (VEGF) family has recently expanded by the identification and cloning of three additional members, namely VEGF-B, VEGF-C, and VEGF-D. In this study we demonstrate that VEGF-B binds selectively to VEGF receptor-1/Flt-1. This binding can be blocked by excess VEGF...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 95; no. 20; pp. 11709 - 11714
Main Authors Olofsson, Birgitta, Korpelainen, Eija, Pepper, Michael S., Mandriota, Stefano J., Aase, Karin, Kumar, Vijay, Gunji, Yuji, Jeltsch, Michael M., Shibuya, Masabumi, Alitalo, Kari, Eriksson, Ulf
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences of the United States of America 29.09.1998
National Acad Sciences
National Academy of Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The vascular endothelial growth factor (VEGF) family has recently expanded by the identification and cloning of three additional members, namely VEGF-B, VEGF-C, and VEGF-D. In this study we demonstrate that VEGF-B binds selectively to VEGF receptor-1/Flt-1. This binding can be blocked by excess VEGF, indicating that the interaction sites on the receptor are at least partially overlapping. Mutating the putative VEGF receptor-1/Flt-1 binding determinants Asp63, Asp64, and Glu67 to alanine residues in VEGF-B reduced the affinity to VEGF receptor-1 but did not abolish binding. Mutational analysis of conserved cysteines contributing to VEGF-B dimer formation suggest a structural conservation with VEGF and platelet-derived growth factor. Proteolytic processing of the 60-kDa VEGF-B186 dimer results in a 34-kDa dimer containing the receptor-binding epitopes. The binding of VEGF-B to its receptor on endothelial cells leads to increased expression and activity of urokinase type plasminogen activator and plasminogen activator inhibitor 1, suggesting a role for VEGF-B in the regulation of extracellular matrix degradation, cell adhesion, and migration.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Edited by M. Judah Folkman, Harvard Medical School, Boston, MA, and approved August 10, 1998
B.O. and E.K. contributed equally to this work, as did K.A. and U.E.
To whom reprint requests should be addressed. e-mail: ueri@licr.ki.se or Kari.Alitalo@helsinki.fi.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.95.20.11709